Alacris Theranostics
European Researchers Developing Cancer Pathway Modeling Platform Combining Omics, Systems Bio Tools
Premium
Called CanPathPro, the research consortium aims to combine omics data and systems biology tools into a single commercial platform for testing cancer hypotheses.
Researchers plan to develop a device that supports nucleic acid sequencing and protein sequencing using plasmonic nanostructures.
Agilent Names Alacris CSP for Target Enrichment
Alacris' ModCell approach matches patients with appropriate therapies.
Alacris Attains Illumina CSPro Certification for NGS
NEW YORK (GenomeWeb News) – Alacris Theranostics today said that is has gained Illumina CSPro certification for next-generation sequencing.
Alacris, GSK Ink Cancer Drug Stratification Deal
NEW YORK (GenomeWeb News) – German firm Alacris Theranostics today announced a deal with GlaxoSmithKline for the application of Alacris' Modcell System for drug stratification.